High Retapamulin CAS 224452-66-8 manufacturer

FOB Reference Price:Get Latest Price
1 Gram/Grams (Min. Order)
Report Suspicious Activity
Overview
Quick Details
CAS No.:
224452-66-8
Other Names:
retapamulin
MF:
C30H47NO4S
EINECS No.:
N/A
Place of Origin:
Shaanxi, China (Mainland)
Type:
Pharmaceutical Intermediates
Purity:
98.5%min
Brand Name:
TOP
Model Number:
TOP130201
Application:
Pharmaceutical intermediates&antibiotics
Appearance:
off-white powder
Packaging & Delivery
Packaging Details
as per clients' requirements
Port
Shanghai
Lead Time :
within 1 month after your payments

Retapamulin
CAS 224452-66-8
M.F. C30H47NO4S

Usage: Antibiotics

Assay:98.5%

Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use. It is marketed as an ointment under the brand names Altabax and Altargo.

Retapamulin was approved by the United States Food and Drug Administration in April 2007 for the treatment of bacterial skin infections such as impetigo. In May 2007, retapamulin received approval in the EU from the European Medicines Agency for the same indication.

Clinical trials have demonstrated its efficacy against certain Gram-positive bacteria including MRSA.

Pharmacology

Mechanism of action

Retapamulin is an antibacterial agent, specifically a protein synthesis inhibitor. The medication selectively inhibits bacterial protein synthesis by interacting at a site on the 50S subunit of the bacterial ribosome through an interaction that differs from other antibiotics.

Pharmakinetics

Systemic exposure following topical application through intact skin is low.

You May Like
Not exactly what you want? 1 request, multiple quotations Get Quotations Now >>
You May Like